- Filed
- Dec 2, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 237.79M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 236.31M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 229.62M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2024 | 228.83M sh |
| Stock Repurchased | Q3 2026 · Oct 31, 2025 | $74.18M |
| Stock Repurchased | Q3 2026 · Oct 31, 2024 | $73.87M |
| Capex | Q3 2026 · Oct 31, 2025 | $2.6M |
| Capex | Q3 2026 · Oct 31, 2024 | $4.06M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | $62.77M |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$930K |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $183.47M |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $184.73M |
| Cash And Equivalents | Q3 2026 · Oct 31, 2024 | $196.77M |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | $188.36M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | $224.56M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | $227.52M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | $239.27M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | $291.92M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | $326.4M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $420.95M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $415.82M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $652.07M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $663.89M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $587.42M |
| Current Assets | Q3 2026 · Jan 31, 2025 | $600.74M |
| Total Assets | Q3 2026 · Oct 31, 2025 | $840.43M |
| Total Assets | Q3 2026 · Jan 31, 2025 | $891.42M |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$0.29 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$0.66 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | −$0.25 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | −$0.84 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$0.29 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$0.66 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | −$0.25 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | −$0.84 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $74.66M |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $151.75M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $36.27M |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $106.18M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $73.81M |
| Rd Expense | Q3 2026 · Oct 31, 2025 | $228.32M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $83.29M |
| Rd Expense | Q3 2026 · Oct 31, 2024 | $257.23M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$68.43M |
| Net Income | Q3 2026 · Oct 31, 2025 | −$156.81M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$57.33M |
| Net Income | Q3 2026 · Oct 31, 2024 | −$193.24M |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$69.99M |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$163.35M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$60.18M |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$203.15M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $178.73M |
| Gross Profit | Q3 2026 · Oct 31, 2025 | $523.48M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $164.08M |
| Gross Profit | Q3 2026 · Oct 31, 2024 | $477.95M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $22.31M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2025 | $61.76M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $19.8M |
| Cost Of Revenue | Q3 2026 · Oct 31, 2024 | $57.59M |
| Revenue | Q3 2026 · Oct 31, 2025 | $201.03M |
| Revenue | Q3 2026 · Oct 31, 2025 | $585.24M |
| Revenue | Q3 2026 · Oct 31, 2024 | $183.88M |
| Revenue | Q3 2026 · Oct 31, 2024 | $535.54M |